The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $493,610 Project Grant from the Department of Defense's Military Medical Research and Development (CFDA 12.420) program to conduct a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The grant, awarded on August 1, 2024, will support this research project over a 3-year period, with a final completion date of July 31, 2027. As...
This federal Project Grant award of $433,126 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to explore the role of PACAP38 in post-traumatic headache. The research aims to investigate innovative medical solutions for the battlefield and transform healthcare for service members and the broader public. UTHSCSA is a prominent Hispanic-serving academic...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $131,685 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, titled "TARGETED AUDITORY PLASTICITY TRAINING TO IMPROVE CENTRAL HEARING IN MILD TBI", will support research to develop innovative approaches for improving central hearing in individuals with mild traumatic brain injury. The grant has a performance...
The University of Texas Health Science Center at San Antonio (UTHSCSA) received a $508,815 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This 4-year award, running from September 1, 2023 to August 31, 2027, will support research to transform healthcare for service members and the public through innovative and...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $1,181,251 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "COMPUTERIZED ANGER MANAGEMENT PROTOCOL (CAMP) FOR SERVICE MEMBERS WITH AND WITHOUT A HISTORY OF MILD TRAUMATIC BRAIN INJURY", will fund research to develop and evaluate a novel computerized anger management protocol for active-duty service members,...
This $3,150,000 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) will fund a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The award was granted to The University of Texas Health Science Center at San Antonio, a Hispanic-serving academic medical institution with extensive...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
The University of Texas Health Science Center at Houston (UTHealth) was awarded a $769,578 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENHANCING BIOENERGETICS AS A STRATEGY TO IMPROVE OUTCOME AFTER MILD TRAUMATIC BRAIN INJURY". The award, which runs from May 1, 2024 to April 30, 2027, will support UTHealth's efforts to advance scientific knowledge and develop innovative treatments for...
The Defense Health Agency awarded a four-year, $936,532 Cooperative Agreement to the University of Texas Health Science Center at San Antonio (UTHSCSA) to implement and evaluate a patient-centered PTSD treatment program for military personnel. This award is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research to transform healthcare for service members and the public. Through this Cooperative Agreement, UTHSCSA will conduct research...